NasdaqCM - Nasdaq Real Time Price USD

Mainz Biomed N.V. (MYNZ)

Compare
4.6700
+0.3900
+(9.11%)
At close: January 13 at 4:00:01 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
895.4790
895.4790
529.8770
577.3480
493.5650
Cost of Revenue
385.8200
385.8200
347.7260
399.7260
370.4800
Gross Profit
509.6590
509.6590
182.1510
177.6220
123.0850
Operating Expense
27,154.3410
27,154.3410
26,626.1910
9,902.2280
479.3860
Operating Income
-26,644.6820
-26,644.6820
-26,444.0400
-9,724.6060
-356.3010
Net Non Operating Interest Income Expense
-809.5810
-809.5810
-289.3240
-339.1710
-268.7920
Other Income Expense
1,158.5360
1,158.5360
346.0280
-1,626.3210
38.1980
Pretax Income
-26,295.7270
-26,295.7270
-26,387.3360
-11,690.0980
-586.8950
Net Income Common Stockholders
-26,295.7270
-26,295.7270
-26,387.3360
-11,690.0980
-586.8950
Diluted NI Available to Com Stockholders
-26,295.7270
-26,295.7270
-26,387.3360
-11,690.0980
-586.8950
Basic EPS
-1.62
-1.62
-1.86
-1.62
-0.05
Diluted EPS
-1.62
-1.62
-1.86
-1.62
-0.05
Basic Average Shares
16,242.3340
16,242.3340
14,157.4920
7,210.8890
11,710.0000
Diluted Average Shares
16,242.3340
16,242.3340
14,157.4920
7,210.8890
11,710.0000
Total Operating Income as Reported
-26,644.6820
-26,644.6820
-26,444.0400
-9,724.6060
-673.7150
Total Expenses
27,540.1610
27,540.1610
26,973.9170
10,301.9540
849.8660
Net Income from Continuing & Discontinued Operation
-26,295.7270
-26,295.7270
-26,387.3360
-11,690.0980
-586.8950
Normalized Income
-26,344.4040
-26,344.4040
-26,387.3360
-9,670.3590
-616.8790
Interest Expense
809.5810
809.5810
289.3240
339.1710
268.7920
Net Interest Income
-809.5810
-809.5810
-289.3240
-339.1710
-268.7920
EBIT
-25,486.1460
-25,486.1460
-26,098.0120
-11,350.9270
-318.1030
EBITDA
-24,619.7340
-24,619.7340
-25,718.2140
-11,280.9980
-257.6410
Reconciled Cost of Revenue
385.8200
385.8200
123.1660
368.1800
343.9200
Reconciled Depreciation
866.4120
866.4120
379.7980
69.9290
60.4620
Net Income from Continuing Operation Net Minority Interest
-26,295.7270
-26,295.7270
-26,387.3360
-11,690.0980
-586.8950
Total Unusual Items Excluding Goodwill
48.6770
48.6770
--
-2,019.7390
29.9840
Total Unusual Items
48.6770
48.6770
--
-2,019.7390
29.9840
Normalized EBITDA
-24,668.4110
-24,668.4110
-25,718.2140
-9,261.2590
-287.6250
12/31/2020 - 11/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DGX Quest Diagnostics Incorporated
154.02
+1.47%
 
CSTL Castle Biosciences, Inc.
26.15
-13.55%
 
TTOO T2 Biosystems, Inc.
0.3200
0.00%
 
APDN Applied DNA Sciences, Inc.
0.1934
-2.18%
 
CHEK Check-Cap Ltd.
1.5000
-1.96%
 
GH Guardant Health, Inc.
38.10
+3.80%
 
ISPC iSpecimen Inc.
2.6800
0.00%
 
STIM Neuronetics, Inc.
2.3400
+36.84%
 
PRPH ProPhase Labs, Inc.
0.6490
0.00%
 
PSNL Personalis, Inc.
5.35
-4.29%